Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
Bone Disorders01:29

Bone Disorders

3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

2.8K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.8K
Bone Cells and Tissue01:30

Bone Cells and Tissue

4.8K
Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
4.8K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

320
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
320

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and characterization of a lytic phage targeting carbapenem-resistant Pseudomonas aeruginosa.

Biochemical and biophysical research communications·2026
Same author

Ionomic profiling of vitreous humor and serum in rhegmatogenous retinal detachment.

Scientific reports·2026
Same author

Retraction notice to"Corrigendum to '25-hydroxycholesterol promotes RANKL-induced osteoclastogenesis through coordinating NFATc1 and Sp1 complex in the transcription of miR-139-5p'" [Biochem. Biophys. Res. Commun. 532 (2020) 166].

Biochemical and biophysical research communications·2026
Same author

Visible-Light-Induced Copper-Catalyzed Coupling Reaction of Aryl Halides with Phenols at Room Temperature.

Organic letters·2026
Same author

Retraction notice to "25-hydroxycholesterol promotes RANKL-induced osteoclastogenesis through coordinating NFATc1 and Sp1 complex in the transcription of miR-139-5p" [Biochem. Biophys. Res. Commun. 485 (2017) 736-741].

Biochemical and biophysical research communications·2026
Same author

Ash2l deficiency impairs adipose tissue thermogenesis and exacerbates obesity in mice.

Cellular & molecular biology letters·2026

Related Experiment Video

Updated: Aug 7, 2025

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

6.4K

CYP27A1 deficiency promoted osteoclast differentiation.

Ziqi Fang1, Guangdong Cheng2, Mengting He3

  • 1Department of Clinical Laboratory, Shandong Provincial Hospital, Shandong University, Jinan, China.

Peerj
|March 9, 2023
PubMed
Summary

CYP27A1 deficiency promotes osteoclast differentiation and bone loss. This study identifies CYP27A1 as a novel therapeutic target for osteoporosis and other bone diseases.

Keywords:
Bone lossCYP27A1Expression profileOsteoclastsRNA sequencing

More Related Videos

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

3.3K
Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells
10:52

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Published on: March 22, 2024

1.7K

Related Experiment Videos

Last Updated: Aug 7, 2025

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

6.4K
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

3.3K
Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells
10:52

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Published on: March 22, 2024

1.7K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Bone Biology

Background:

  • Elevated osteoclast differentiation disrupts bone homeostasis, leading to bone loss and diseases like osteoporosis.
  • The molecular mechanisms regulating osteoclast formation are complex, with many pathways involved.
  • The specific role of CYP27A1 in osteoclast differentiation remained unexplored prior to this study.

Purpose of the Study:

  • To investigate the role of CYP27A1 in osteoclast differentiation.
  • To explore the molecular mechanisms by which CYP27A1 influences bone homeostasis.
  • To determine if CYP27A1 represents a potential therapeutic target for bone diseases.

Main Methods:

  • CYP27A1 deficient mice were generated using the CRISPR-Cas9 system.
  • Osteoclast differentiation was assessed via Tartrate-resistant acid phosphatase (TRAP) staining.
  • Gene expression changes were analyzed using RNA-sequencing (RNA-seq), with validation through quantitative real-time PCR (qRT-PCR) and Western blotting.

Main Results:

  • CYP27A1 knockout (KO) significantly enhanced osteoclast differentiation and induced bone loss.
  • RNA-seq identified differential expression of genes including ELANE, LY6C2, S100A9, GM20708, BGN, SPARC, and COL1A2 in CYP27A1 KO mice.
  • Enrichment analysis revealed that these differentially expressed genes are associated with key osteogenesis-related signaling pathways, including PPAR signaling, IL-17 signaling, and PI3K/AKT signaling.

Conclusions:

  • CYP27A1 plays a crucial role in regulating osteoclast differentiation.
  • The findings suggest that modulating CYP27A1 activity could be a viable therapeutic strategy for osteoclast-related bone diseases.
  • CYP27A1 emerges as a novel molecular target for treating conditions characterized by excessive bone resorption.